The future is arriving badly explained.
The ideas changing the world.
And what they mean for you.
Selected on · Four signals worth your attention.
Kolibri Opens a German-English AI Model to Local Deployment
Aleph Alpha released Kolibri with downloadable model weights under Apache 2.0. Organizations can run the German-English model on their own infrastructure, but its roughly 78-gigabyte memory footprint still requires substantial computing hardware.
RNA Therapy Raises a Muscle Protein in Three Boys
Ractigen reported that its experimental RNA therapy raised the muscle-protecting protein utrophin 3.5–5.3-fold in three boys with Duchenne muscular dystrophy. The small, uncontrolled study supports the mechanism, but does not establish clinical benefit.
A Blood-Cancer Drug Moves Into First-Line Treatment
The FDA expanded Jaypirca’s approval to adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma who lack a known chromosome 17p deletion. The decision adds an initial treatment option for this defined group.
An AI-Designed Hair-Loss Drug Advances Toward Human Testing
XtalPi says its hair-loss drug program has entered safety and manufacturing studies needed before seeking permission for human trials. Encouraging mouse results support further development, but do not show that the treatment works in people.
Latest
Pick a frontier.
Seven fields. A clear place to begin.
Follow the question.
Selected stories about what changes for us.
Stay ahead
of the story.
A personal take on the week. By Dorian.
Occasional editions. Free to subscribe.
Unsubscribe anytime.